Nandan Padukone
Chief Executive Officer at ImmunoMolecular Therapeutics, Inc.
Network origin in Nandan Padukone first degree
Entity | Entity type | Industry | |
---|---|---|---|
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO.
6
| Holding Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nandan Padukone via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ZOGENIX, INC. | Pharmaceuticals: Major | Founder | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Pharmaceuticals: Generic | Director/Board Member | |
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Chairman | |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Chairman | |
CODEXIS, INC. | Chemicals: Specialty | Chief Executive Officer | |
Suffolk University | College/University | Masters Business Admin | |
Babson College | College/University | Undergraduate Degree | |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ebi Life Sciences, Inc.
Ebi Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ebi Life Sciences, Inc. is a private company that specializes in researching and developing life sciences. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
Respironics Ltd.
Respironics Ltd. Financial ConglomeratesFinance Respironics Ltd. develops and manufactures medical and healthcare products. Its products include Porta-Neb, Freeway Freedom, Sidestream, and Ventstream. The company was founded in 1977 and is headquartered in Bognor Regis, the United Kingdom. | Financial Conglomerates | Sales & Marketing | |
Association of Needle-Free Injection Manufacturers | Chairman | ||
The University of Sheffield | College/University | Undergraduate Degree | |
University of Portsmouth | College/University | Masters Business Admin | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SteadyMed Therapeutics, Inc.
SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Medical/Nursing Services | Chief Executive Officer | |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Director/Board Member | |
BIOPLUS ACQUISITION CORP. | Financial Conglomerates | Chairman | |
ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member | |
Avigen, Inc.
Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | Director/Board Member | |
Physic Ventures LLC
Physic Ventures LLC Investment ManagersFinance Physic Ventures LLC (Physic Ventures) is a venture capital firm founded in 2006 by Dion Madsen and Will B. Rosenzweig. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
University of London | College/University | Doctorate Degree | |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO |
Statistics
International
United States | 35 |
United Kingdom | 7 |
Israel | 3 |
Canada | 2 |
Sectoral
Health Technology | 27 |
Consumer Services | 6 |
Commercial Services | 4 |
Finance | 4 |
Health Services | 3 |
Operational
Director/Board Member | 20 |
Director of Finance/CFO | 12 |
President | 8 |
Chief Executive Officer | 8 |
Chairman | 6 |
Most connected contacts
Insiders | |
---|---|
Jonathan Rigby | 16 |
Stephen Dilly | 15 |
Thomas A. Shea | 15 |
Peter Gottlieb | 1 |
Aaron Michels | 1 |
Ed Orr | 1 |
- Stock Market
- Insiders
- Nandan Padukone
- Company connections